Clinical Study
-
Spine
Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using ZIP™ MIS Interspinous Fusion System
Initial results show ZIP device to be effective and safe CARLSBAD, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) — Aurora Spine…
Read More » -
Recon
RSIP Vision Presents Successful Preliminary Results from Clinical Study of 2D-to-3D Knee Bones Reconstruction
A tool for reconstruction of a 3D model of the knee from 2D X-ray images is being evaluated on clinical…
Read More » -
Spine
Genesys Spine® Announces First Patients Enrolled in The SIros™ Lateral Sacroiliac Joint Fusion Study
AUSTIN, Texas, Oct. 21, 2022 /PRNewswire/ — Genesys Spine announced today the first two patients have been enrolled in the prospective SIros™ Lateral…
Read More » -
Spine
Spine BioPharma Announces First Patient Treated in U.S. Phase 3 Clinical Study
SB-01 For Injection Offers New Potential Treatment for Patients Sufferingfrom Chronic Low Back Pain NEW YORK, September 7, 2022 – OrthoSpineNews…
Read More » -
Biologics
BioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
— First Site Will Enroll First Patient in the Clinical Study– MELVILLE, NY., June 13, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies,…
Read More » -
Biologics
Lipogems® Receives IDE Approval From The U.S. FDA To Begin A Pivotal Clinical Study On The Safety And Effectiveness Of The Lipogems System For The Treatment of Knee Osteoarthritis
ATLANTA , June 10, 2022 /PRNewswire/ — Lipogems is pleased to announce the unconditional approval by the U.S. Food and Drug Administration (FDA) to…
Read More » -
Spine
Centinel Spine Clinical Study for Total Disc Replacement for 2-Level Symptomatic Cervical Disc Disease
SAN ANTONIO, May 24, 2022 /PRNewswire/ — Texas Spine Care Center announced today their 10th patient enrolled in the Centinel Spine, LLC, Multicenter,…
Read More » -
Spine
Spine BioPharma Initiating U.S. Phase 3 Clinical Study
SB-01 For Injection Offers New Potential Treatment for Patients Sufferingfrom Chronic Low Back Pain. New York, NY., May 11, 2022…
Read More » -
Extremities
Stryker’s InSpace subacromial balloon spacer two-year, Level 1 randomized controlled clinical study published in the Journal of Bone and Joint Surgery
InSpace implant demonstrated to be a viable option for patients with massive irreparable rotator cuff tears.* KALAMAZOO, Mich., May 3, 2022 /PRNewswire/…
Read More » -
Recon
New Study Shows No Revisions and a Low Complication Rate for Exactech’s Vantage® Total Ankle Fixed Bearing System
April 14, 2022 GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement…
Read More » -
Recon
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1
Study included only patients with a fully personalized Conformis implant in one knee after previously receiving a competitive off-the-shelf implant in…
Read More » -
Biologics
aap launches world’s first human clinical study for antibacterial silver coating technology on anatomical plates and screws for fracture treatment
Press Release dated December 10, 2021 aap Implantate AG (“aap” or the “Company”) announces that the human clinical study for its…
Read More » -
Spine
Premia Spine’s TOPS™ Spinal Arthroplasty System Yields Positive Patient Outcomes at 6 Weeks Through 12 Months
Intermediate clinical study results presented at SMISS 2021 November 4, 2021 NORWALK, Conn.–(BUSINESS WIRE)–Premia Spine, a medical technology company aiming…
Read More » -
Spine
New Publication Supports Clinical Effectiveness of Centinel Spine’s STALIF® Integrated Interbody™ System
WEST CHESTER, Pa., Oct. 26, 2021 /PRNewswire/ — Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal…
Read More » -
Recon
Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants
A retrospective review of 540 procedures performed demonstrated 98.5% Implant Survivorship and 89.0% Patient Satisfaction for the Conformis patient-specific iTotal®…
Read More »